CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Insights into Crystal Growth and Polymorphism in Active Pharmaceutical Ingredients: Investigating the Role of Specific Interactions for Polymorphic Stability and Transformations using Molecular Simulation
Stockholm University, Faculty of Science, Department of Chemistry.ORCID iD: 0000-0002-4202-1083
2026 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

In the manufacturing of pharmaceutical products, polymorphism - the ability of the active pharmaceutical ingredient (API) to crystallize in several structures with different physicochemical properties - constitutes a major problem. Transitions between different polymorphic forms can occur in the primary crystallization step, but also at multiple points in the secondary processing workflow, as the compounds come into contact with different solvents or are exposed to thermal and mechanical stresses. Mechanistic information is not always easy to obtain due to the variety of conditions and unsystematic nature of the polymorph search.

In this thesis, the possibilities of using molecular simulation as a tool in the study of API polymorphism are evaluated on the case of carbamazepine. Special attention is placed on the importance of specific interactions as driving forces of the transformations between forms.

In the case of the polymorphic transformation of anhydrous carbamazepine in aqueous systems, the driving force for crystal growth on the main surfaces of the polymorphs is quantified and linked to the polarity of the part of the molecule in contact with the solvent. Defect growth is also predicted for a number of the evaluated surfaces.

Next, the reliability of simulation methods in the prediction of the equilibrium solubility is explored on the example of several APIs of varying flexibility. Problems in the accuracy of these methods can be attributed to the description of the molecular interactions in the solid state for more rigid molecules, such as carbamazepine. While the solution state seems to be modeled adequately for these compounds, the description of the interactions for larger and more flexible molecules with the solvent shows a need for further refinement.

Exposure to solvent can often trigger a solution-mediated polymorphic transition from a metastable form to the thermodynamically stable form. The mechanism of this transition is investigated for carbamazepine by exploring both the dissolution at the main faces of the metastable crystal and the behavior of the molecules in solution. It is found that both the type of solvent used and the crystallographic facet play a role in the dissolution process. The interactions of carbamazepine in solution suggest the formation of a possible precursor of the thermodynamically stable form in certain solvents, which might drive its nucleation.

The effect of mechanical stress on the stable form is explored in a separate study, since it has been shown to convert to another metastable form in ball milling, a common step in manufacturing. The microscopic changes in structure under high-pressure shear are found to depend on the magnitude of pressure, shearing speed and the crystallographic facet that is sheared. Evidence is found for the amorphization of the stable form under shear stress, but the retention of certain dimer motifs seen in both the stable and the metastable form suggests that there may be some structural matching facilitating the polymorphic transition. 

Since the methodologies used in these studies are easily transferable to other active ingredients, we hope that they will guide future polymorph screening approaches and ultimately lead to an efficient and systematic way of evaluating the effect of polymorphism on pharmaceutical drug products.

Place, publisher, year, edition, pages
Stockholm: Department of Chemistry, Stockholm University , 2026. , p. 101
Keywords [en]
Polymorphism, Active Pharmaceutical Ingredients, Molecular Dynamics, Carbamazepine
National Category
Physical Chemistry
Research subject
Physical Chemistry
Identifiers
URN: urn:nbn:se:su:diva-256721ISBN: 978-91-8107-676-9 (print)ISBN: 978-91-8107-677-6 (electronic)OAI: oai:DiVA.org:su-256721DiVA, id: diva2:2072264
Public defence
2026-09-08, Magnélisalen, Kemiska Övningslaboratoriet, Svante Arrhenius väg 16B, Stockholm, 13:00 (English)
Opponent
Supervisors
Available from: 2026-08-14 Created: 2026-06-15 Last updated: 2026-08-06Bibliographically approved
List of papers
1. Exploring Carbamazepine Polymorph Crystal Growth in Water by Enhanced Sampling Simulations
Open this publication in new window or tab >>Exploring Carbamazepine Polymorph Crystal Growth in Water by Enhanced Sampling Simulations
2024 (English)In: ACS Omega, E-ISSN 2470-1343, Vol. 9, no 34, p. 36718-36731Article in journal (Refereed) Published
Abstract [en]

In this work, the polymorphism of the active pharmaceutical ingredient carbamazepine (CBZ) was investigated by using molecular dynamics simulations with an enhanced sampling scheme. A single molecule of CBZ attaching to flat surfaces of different polymorphs was used as a model for secondary nucleation in water. A novel approach was developed to compute the free energy profile characterizing the adsorption of molecules with orientation aligned with the crystal structure of the surface. The distribution of states that showed alignment was used to rescale the adsorption free energy to include only the contribution that is consistent with crystal growth. The resulting free energy surfaces showed favorable thermodynamics for the most stable form, Form III and the second most stable form, Form I. The primary crystallization product, a dihydrate, was found to be less favorable, implying a nonclassical crystallization pathway. We suggest that a major contribution determining the energetics is the hydrophobicity of the surface. This thermodynamic ranking provides valuable information about the molecular pathways of polymorph growth and will further contribute to the understanding of the crystallization process of CBZ, which is imperative since polymorph formation can alter the physical properties of a drug significantly.

National Category
Physical Chemistry
Identifiers
urn:nbn:se:su:diva-239224 (URN)10.1021/acsomega.4c05458 (DOI)001293327600001 ()2-s2.0-85201673261 (Scopus ID)
Available from: 2025-02-10 Created: 2025-02-10 Last updated: 2026-06-15Bibliographically approved
2. Estimating the Solubility of Active Pharmaceutical Ingredients Using Molecular Dynamics
Open this publication in new window or tab >>Estimating the Solubility of Active Pharmaceutical Ingredients Using Molecular Dynamics
2025 (English)In: Crystal Growth & Design, ISSN 1528-7483, E-ISSN 1528-7505, Vol. 25, no 17, p. 7155-7165Article in journal (Refereed) Published
Abstract [en]

The solubility of molecular crystals is of interest in many areas of chemistry, of which pharmaceutical applications are of particular importance. Predicting solubility using atomistic first-principle methods, that compare the chemical potential of the solid and the solvated phase, has become more common, but remains challenging due to the difficulty in modeling both the crystal form, including its polymorphs, and the interactions with the solvent. Here we aim to compute the solubilities of three active pharmaceutical ingredients of increasing size and complexity: paracetamol, carbamazepine and indomethacin. The known anhydrous polymorphs of each compound are considered in the calculation of the free energy of the solid form and the solvation is explored both in water and in some organic solvents (ethanol, methanol and acetonitrile). The compounds are categorized as poorly soluble or well-soluble based on the comparison of the solid form free energy and the solvation free energy of a single molecule at infinite dilution. Poor solubility then prompts the use of a solubility estimation based on excess free energies, while for well-soluble molecules their chemical potential has to be calculated as a function of concentration. This is done using the recently developed S0 method. While promising results are obtained for paracetamol, carbamazepine and indomethacin predictions systematically underestimate the solubility. This can be ascribed to incomplete descriptions of intermolecular interactions by the force field, but the order of stability of the solid forms and systematic nature of the deviations point toward additional problems originating in the accuracy of the method used to calculate the solid free energies.

National Category
Physical Chemistry
Identifiers
urn:nbn:se:su:diva-247337 (URN)10.1021/acs.cgd.5c00627 (DOI)001551097300001 ()2-s2.0-105015453281 (Scopus ID)
Available from: 2025-09-25 Created: 2025-09-25 Last updated: 2026-06-15Bibliographically approved
3. The role of dissolution, crystal growth and specific interactions in the solvent-mediated transformation of carbamazepine form II investigated by molecular dynamics
Open this publication in new window or tab >>The role of dissolution, crystal growth and specific interactions in the solvent-mediated transformation of carbamazepine form II investigated by molecular dynamics
(English)Manuscript (preprint) (Other academic)
Abstract [en]

Solution-mediated polymorphic transitions of active pharmaceutical ingredients are of particular interest to the optimization of the drug manufacturing process since the exposure of raw crystal material to solvent is a common occurrence. This paper explores the transition of the metastable form II of carbamazepine to its stable form III in ethanol, 2-propanol, acetonitrile and nitromethane by means of molecular dynamics. Simulations of saturated solutions of carbamazepine at different supersaturation ratios revealed strong interactions between the alcohols and the solute, while carbamazepine molecules interacted more with each other in acetonitrile and nitromethane. A dimer aggregate that could serve as a precursor for the stable form III could be seen in all solvents. Slabs of the 001, 010 and 100 faces of form II in the solvents showed some dissolution at lower supersaturation, while very high concentrations stabilized the interfaces in most solvents. When placed in a severely undersaturated solvent, dissolution occurred preferentially at the 001 surface in all solvents except 2-propanol.Based on the combined results the transformation is confirmed to be dissolution-controlled in 2-propanol, while in ethanol, acetonitrile and nitromethane, the transformation is likely dominated by both the nucleation and crystal growth of the stable form III. On the basis of the solvent properties it is suggested that a potential stabilizing additive should show strong hydrogen bonding at the 001 surface, but interact with the 010 and 100 surfaces via non-polar parts.

National Category
Physical Chemistry
Identifiers
urn:nbn:se:su:diva-256743 (URN)
Available from: 2026-06-15 Created: 2026-06-15 Last updated: 2026-08-06
4. Investigating the deformation of carbamazepine form III under shear stress
Open this publication in new window or tab >>Investigating the deformation of carbamazepine form III under shear stress
(English)Manuscript (preprint) (Other academic)
Abstract [en]

The transformation of the stable form III of carbamazepine to its metastable form IV has been observed in mechanochemical processes under a range of different conditions, of which several highlight the role of amorphization in the process. This paper models the effect of shear stress on three different facets of form III, which are first roughened up and, subsequently, collided at two different nominal velocities. From this, three configurations at different pressures are extracted and sheared against each other at different shearing velocities. The loss of crystallinity can be seen both visually in the increased amorphous material generated in the middle of the slabs, and using a collective variable that depends on the relative orientations of the molecules to each other. The latter is also used to assess separately the effect of the shearing on the hydrogen bonded network and the non-polar interactions. The 010 surface showed the largest ’ripple effect’ in amorphization with both types of interactions affected equally. On the other hand the 100 surface suffered a loss of hydrogen bonding and the 001 surface decreased in aromatic, non-polar interactions. It is speculated that the preserved orientation of the aromatic parts of the molecule can facilitate the nucleation of the stable form III, which shows the same orientations in its aromatic system. However, it is more likely that the main effect of shear stress is increased amorphization on all facets.

National Category
Physical Chemistry
Research subject
Physical Chemistry
Identifiers
urn:nbn:se:su:diva-256722 (URN)
Available from: 2026-06-15 Created: 2026-06-15 Last updated: 2026-08-06

Open Access in DiVA

Insights into Crystal Growth and Polymorphism in Active Pharmaceutical Ingredients(20642 kB)53 downloads
File information
File name FULLTEXT01.pdfFile size 20642 kBChecksum SHA-512
a703342f9f20cdd8c32f586a939b935f37bc9b2fbff560f10fa789ffa31ddfbbeda49032a89eb6a14ce27065502c83c8ba1fba322574b6c4815fa0bb590e04dc
Type fulltextMimetype application/pdf

Authority records

Herboth, Radost

Search in DiVA

By author/editor
Herboth, Radost
By organisation
Department of Chemistry
Physical Chemistry

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

isbn
urn-nbn

Altmetric score

isbn
urn-nbn
Total: 7764 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf